Cold Blister Packaging Effective Choice Pharmaceutical Market Size, Share, Growth Analysis, By material(Paper & Paperboard, Plastics Films, Aluminium), By Type of technology(Thermoforming and Cold Forming), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2252 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 61 |Figures: 75

Cold Blister Packaging Effective Choice Pharmaceutical Market Insights

Cold Blister Packaging Effective Choice Pharmaceutical Market size was valued at USD 3.44 billion in 2021 and is poised to grow from USD 3.70 billion in 2022 to USD 6.60 by 2030, at a CAGR of 7.5% during the forecast period (2023-2030).

Cold form blister packs are made with Aluminum foil which is sandwiched between Polyvinyl Chloride (PVC) and nylon (oPA) films during the production of cold form blister packs utilising dry bond lamination technology. Without using heat, a stamp merely presses the film laminate into the mould. Consequently, the substance is known as cold forming blister laminate. One of laminate's main benefits is that it completely seals out both oxygen and water, extending the shelf life of the product due to the laminate's thicker foil. However, a significant issue for these producers is the slower manufacturing speed as compared to thermoforming, which impacts the supply and demand chain as a whole. One of the challenges experienced by producers is the lack of transparency of the package and the increasing size of the blister card. The cold form blister packaging has grown due to rising healthcare product demand and the viability of the pharmaceutical and medical industries. And it is expected that Over the forecast year, this tendency is anticipated to persist.

Pharmaceuticals and medical devices are both included in the healthcare sector's substantial use of cold form blister packaging. It is employed by the pharmaceutical sector to package a variety of goods, such as tablets, capsules, medications, vials, ampoules, syringes, and liquids. Cold form foils with features like push-through, peelable, peel-push, tear-open, and child resistance are produced depending on the needs of pharmaceutical clients across the world. These specific solutions are provided by international blister pack manufacturers for newly introduced therapeutic areas, novel procedures, and other specialist healthcare uses.

US Cold Blister Packaging Effective Choice Pharmaceutical Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 3.44 billion

Largest Segment

Thermoforming

Fastest Growth

Thermoforming

Growth Rate

7.5% CAGR

Global Cold Blister Packaging Effective Choice Pharmaceutical Market ($ Bn)
Country Share for Asia Pacific Region (%)

To get more reports on the above market click here to Buy The Report

Cold Blister Packaging Effective Choice Pharmaceutical Market Segmental Analysis

cold blister packaging effective choice pharmaceutical industry is segmented based Material, technology, and region. Based on Material, it is classified into Paper & Paperboard, Plastics Films, Aluminium. Based on type of technology, it is classified into Thermoforming and Cold Forming. Based on Region, it is categorized into North America, Europe, Asia-Pacific, CSA and MEA.

Cold Blister Packaging Effective Choice Pharmaceutical Market Analysis by Material

In terms of material, plastic films are expected to be the largest and fastest growing material segment in the forecasting year. This is attributed to the product's outstanding visibility and the safe and appealing packaging.

Cold Blister Packaging Effective Choice Pharmaceutical Market Analysis by Technology

Based on type technology, the pharmaceutical business uses thermoforming packaging extensively for the packaging of tablets, capsules, and other medical supplies or equipment. For blister packing, the thermoforming method is chosen over cold forming since it requires less expensive starting tools and equipment. Cold form blister packaging, on the other hand, provides high barrier protection, product integrity, a minimal risk of unintentional overdose, adherence to patient-favouring norms, and manufacture of recognisable single doses.

Global Cold Blister Packaging Effective Choice Pharmaceutical Market By technology (%)

To get detailed analysis on other segments, Request For Free Sample Report

Cold Blister Packaging Effective Choice Pharmaceutical Market Regional Insights

The Asia Pacific region dominated the cold blister packaging effective choice pharmaceutical industry in 2021. China had the highest revenue share—more than 30.0%. The country's access to raw materials like PVC and aluminium is assisting the market's expansion. According to a report from the Government of Canada, the China had  produced 36 million tonnes in 2019, followed by India, Russia, and Canada,   The value of the market is being driven by the presence of significant players in the area, including Shanghai Haishun New Pharmaceutical Packaging Ltd. and Ningbo Dragon Packaging Technology Co., Ltd. Market Dynamics. Further, the increasing prevalence of contract manufacturing across growing countries like China and India is contributing to the market growth in the country. India is anticipated to expand at the fastest rate IN the forecasting year. This is because of rising investments in the region's healthcare sector and government support for the growth and progress of the pharmaceutical industry in the country. Another important element promoting the development of the market in the nation is the rising prevalence of chronic disorders among the populace.

Global Cold Blister Packaging Effective Choice Pharmaceutical Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cold Blister Packaging Effective Choice Pharmaceutical Market Dynamics

Cold Blister Packaging Effective Choice Pharmaceutical Market Drivers

Consumer Demand for Improved Structure to Bolster Market Growth

  • The main factor driving market expansion is the rise in the use of blister packaging for tablets and capsules. blister packaging is extensively employed in tablets and capsules. Individual capsules are frequently kept in a bigger carton using blister packing, which shields the contents from contamination. The most common material structure utilized to produce blister packs all around the world is the OPA/Al/PVC multilayer structure. Additionally, blister packs can shield materials from environmental influences including contamination and humidity for prolonged periods. Thus due to its convenient usage it has driven the cold blister packaging effective choice pharmaceutical industry significantly.
  • Traditional bottles have gradually lost popularity among consumers in favour of blister packaging, which is unit-dose packaging, for pharmaceutical products. Blister packs are used to package pharmaceuticals and medical supplies in the healthcare industry. They are used for a variety of other things in the consumer goods, industrial, and food industries. Additionally, blister packaging uses fewer resources for packing, has a great hang-hook presentation, and takes up less room on store shelves. As a result, blister packs are more reasonably priced and economical than other packaging options like hard bottles.

Cold Blister Packaging Effective Choice Pharmaceutical Market Restraints

Limited Design Flexibility and Environmental Concerns to Hinder Market Growth

  • Cold blister packaging often has limited design flexibility in terms of shape, size, and branding options. Pharmaceutical companies may find it challenging to differentiate their products on the market due to the standardized nature of cold-formed blisters. Creative packaging designs can play a crucial role in branding and product recognition, and these opportunities might be constrained by the limitations of cold blister packaging.The environmental impact of cold blister packaging is a growing concern, particularly due to the extensive use of plastics. The pharmaceutical industry is under increasing pressure to adopt sustainable packaging practices to minimize plastic waste and reduce carbon emissions. Cold blister packaging may contribute to these challenges, as the disposal and recycling of such packaging materials can be complex and may not align with emerging eco-friendly packaging trends.

Request Free Customization of this report to help us to meet your business objectives.

Cold Blister Packaging Effective Choice Pharmaceutical Market Competitive Landscape

The global cold blister packaging effective choice pharmaceutical market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Cold Blister Packaging Effective Choice Pharmaceutical Market Top Player's Company Profiles

  • Amcor plc
  • Bemis Company, Inc. (now part of Amcor)
  • WestRock Company
  • Constantia Flexibles Group GmbH
  • Uflex Ltd.
  • Bilcare Limited
  • Tekni-Plex, Inc.
  • Klöckner Pentaplast Group
  • Huhtamaki Group
  • Winpak Ltd.
  • Essentra plc
  • Wipak Group
  • Almac Group
  • DPH (Delhi Print House)
  • R-Pharm Germany GmbH
  • Auger Packaging
  • Keystone Folding Box Co.
  • MPI Label Systems
  • Multivac Group
  • Romaco Group

 Cold Blister Packaging Effective Choice Pharmaceutical Market Recent Developments

  • In March 2022, PureCycle Technologies, Inc. (Nasdaq: PCT), a manufacturer and distributor of premium packaging products for perishable foods, beverages, and healthcare, announced today that it will supply Winpak with Ultra-Pure Recycled (UPR) Polypropylene (PP) from its newest facility, which will be built in Augusta, Georgia. Winpak Ltd. (WPK) is a manufacturer and distributor of premium packaging products for perishable foods, beverages, and healthcare.
  • In July 2022, Amcor (NYSE: AMCR, ASX: AMC), a leader in creating ethical packaging solutions, was recognised twice for its advancements in environmentally friendly packaging.

Cold Blister Packaging Effective Choice Pharmaceutical Key Market Trends

  • The expansion of the generic market, escalation of financial investment in the pharmaceutical, marketing products through e-commerce, and fast rising drug delivery industry are further predicted to enhance the market growth. The market dynamics have been altered by oral ingestible containers, inhalers, nasal sprays, and other comparable items, which are expected to encourage the expansion of pharmaceutical packaging. The demand for packaging is rising as a result of rising customer demands for convenience and better sealing characteristics, increased demand for a variety of products, and enhanced environmental norms.

Cold Blister Packaging Effective Choice Pharmaceutical Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to the cold blister packaging effective choice pharmaceutical industry analysis, in terms of technology, thermoforming segment And in terms of material, the Plastic films has contributed at largest rate in the cold blister packaging effective choice pharmaceutical industry. Moreover, Cost-effectiveness Is the key factor in the growth market. whereas, the Emerging economies can contribute high growth potential in forecasting years. Additionally Stringent regulations which are imposed on blister packaging in the pharmaceutical industry, may pose a greatest challenge to the blister packaging market in the forecasting year.

Report Metric Details
Market size value in 2023 USD 3.44 billion
Market size value in 2031 USD 6.60
Growth Rate 7.5%
Forecast period 2024-2031
Forecast Unit (Value) USD
Segments covered
  • material
    • Paper & Paperboard, Plastics Films, Aluminium
  • Type of technology
    • Thermoforming and Cold Forming
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Amcor plc
  • Bemis Company, Inc. (now part of Amcor)
  • WestRock Company
  • Constantia Flexibles Group GmbH
  • Uflex Ltd.
  • Bilcare Limited
  • Tekni-Plex, Inc.
  • Klöckner Pentaplast Group
  • Huhtamaki Group
  • Winpak Ltd.
  • Essentra plc
  • Wipak Group
  • Almac Group
  • DPH (Delhi Print House)
  • R-Pharm Germany GmbH
  • Auger Packaging
  • Keystone Folding Box Co.
  • MPI Label Systems
  • Multivac Group
  • Romaco Group
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cold Blister Packaging Effective Choice Pharmaceutical Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cold Blister Packaging Effective Choice Pharmaceutical Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cold Blister Packaging Effective Choice Pharmaceutical Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cold Blister Packaging Effective Choice Pharmaceutical Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cold Blister Packaging Effective Choice Pharmaceutical Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cold Blister Packaging Effective Choice Pharmaceutical Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Cold Blister Packaging Effective Choice Pharmaceutical Market size was valued at USD 3.44 billion in 2021 and is poised to grow from USD 3.70 billion in 2022 to USD 6.60 by 2030, at a CAGR of 7.5% during the forecast period (2023-2030).

The cold blister packaging effective choice pharmaceutical market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Amcor plc', 'Bemis Company, Inc. (now part of Amcor)', 'WestRock Company', 'Constantia Flexibles Group GmbH', 'Uflex Ltd.', 'Bilcare Limited', 'Tekni-Plex, Inc.', 'Klöckner Pentaplast Group', 'Huhtamaki Group', 'Winpak Ltd.', 'Essentra plc', 'Wipak Group', 'Almac Group', 'DPH (Delhi Print House)', 'R-Pharm Germany GmbH', 'Auger Packaging', 'Keystone Folding Box Co.', 'MPI Label Systems', 'Multivac Group', 'Romaco Group'

The main factor driving market expansion is the rise in the use of blister packaging for tablets and capsules. blister packaging is extensively employed in tablets and capsules. Individual capsules are frequently kept in a bigger carton using blister packing, which shields the contents from contamination. The most common material structure utilized to produce blister packs all around the world is the OPA/Al/PVC multilayer structure. Additionally, blister packs can shield materials from environmental influences including contamination and humidity for prolonged periods. Thus due to its convenient usage it has driven the cold blister packaging effective choice pharmaceutical industry significantly.

The expansion of the generic market, escalation of financial investment in the pharmaceutical, marketing products through e-commerce, and fast rising drug delivery industry are further predicted to enhance the market growth. The market dynamics have been altered by oral ingestible containers, inhalers, nasal sprays, and other comparable items, which are expected to encourage the expansion of pharmaceutical packaging. The demand for packaging is rising as a result of rising customer demands for convenience and better sealing characteristics, increased demand for a variety of products, and enhanced environmental norms.

The Asia Pacific region dominated the cold blister packaging effective choice pharmaceutical industry in 2021. China had the highest revenue share—more than 30.0%. The country's access to raw materials like PVC and aluminium is assisting the market's expansion. According to a report from the Government of Canada, the China had  produced 36 million tonnes in 2019, followed by India, Russia, and Canada,   The value of the market is being driven by the presence of significant players in the area, including Shanghai Haishun New Pharmaceutical Packaging Ltd. and Ningbo Dragon Packaging Technology Co., Ltd. Market Dynamics. Further, the increasing prevalence of contract manufacturing across growing countries like China and India is contributing to the market growth in the country. India is anticipated to expand at the fastest rate IN the forecasting year. This is because of rising investments in the region's healthcare sector and government support for the growth and progress of the pharmaceutical industry in the country. Another important element promoting the development of the market in the nation is the rising prevalence of chronic disorders among the populace.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Cold Blister Packaging Effective Choice Pharmaceutical Market

Report ID: SQMIG35I2252

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE